Expansion of the Chinese pharmaceutical market and the growing presence of major Western pharmaceutical companies

「China’s pharmaceutical market continues to expand as incomes rise and chronic diseases increase. In the third quarter of 2019, U.S. companies Merck and Pfizer and the U.K.’s AstraZeneca steadily increased sales of new cardiovascular and cancer drugs in China, further enhancing the importance of the Chinese market to major Western pharmaceutical companies.」